Trial intelligence / Profile preview

Crisaborole application rates in atopic dermatitis

NCT03868098Phase 4Completed

Sponsor
Innovaderm Research
Start
May 2019
Primary completion
Nov 2020
Countries
1
01

Overview

A Phase 4 trial of AN2728 ointment vehicle in atopic dermatitis (AD), sponsored by Innovaderm Research. Started May 2019; status: completed.

02

Drugs

AN2728 ointment vehicle
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on NCT03868098.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03868098.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call